QUOIN PHARMACEUTICALS, LTD.

(QNRX)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
4.780 USD   -0.83%
08/11Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th
AQ
08/11QUOIN PHARMACEUTICALS : Announces Pricing of $16.8 Million Upsized Public Offering - Form 6-K
PU
08/09Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Rebound Late

07/01/2022 | 04:08pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AGILE THERAPEUTICS, INC. -11.93% 0.565 Delayed Quote.-97.11%
ASTRAZENECA PLC 1.96% 10712 Delayed Quote.23.44%
CERTARA, INC. -13.03% 17.56 Delayed Quote.-38.21%
NASDAQ COMPOSITE 2.09% 13047.19 Real-time Quote.-17.83%
PIPER SANDLER COMPANIES 0.66% 131.88 Delayed Quote.-26.12%
QUOIN PHARMACEUTICALS, LTD. -0.83% 4.78 Delayed Quote.-78.99%
All news about QUOIN PHARMACEUTICALS, LTD.
08/11Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corpo..
AQ
08/11QUOIN PHARMACEUTICALS : Announces Pricing of $16.8 Million Upsized Public Offering - Form ..
PU
08/09Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
AQ
08/05Top Midday Decliners
MT
08/05Quoin Pharmaceuticals Prices Offering of Ordinary Shares, Pre-Funded Warrants; Stock Pl..
MT
08/05Quoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public Offering
AQ
08/05Top Premarket Decliners
MT
08/02Top Premarket Gainers
MT
07/28Quoin Pharmaceuticals Announces Receipt of Constructive Scientific Advice from EMA for ..
AQ
07/28Quoin Pharmaceuticals Announces Receipt of Constructive Scientific Advice from EMA for ..
CI
More news
Analyst Recommendations on QUOIN PHARMACEUTICALS, LTD.
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -11,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -0,07x
Yield 2022 -
Capitalization 6,86 M 6,86 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 4
Free-Float 0,24%
Chart QUOIN PHARMACEUTICALS, LTD.
Duration : Period :
Quoin Pharmaceuticals, Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUOIN PHARMACEUTICALS, LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 4,78 $
Average target price 52,03 $
Spread / Average Target 989%
EPS Revisions
Managers and Directors
Michael Myers Chairman & Chief Executive Officer
Gordon B. Dunn Chief Financial Officer
Denise Carter Chief Operating Officer & Director
Dennis H. Langer Independent Director
Natalie Leong Independent Director
Sector and Competitors
1st jan.Capi. (M$)
QUOIN PHARMACEUTICALS, LTD.-78.99%7
MODERNA, INC.-32.60%67 212
LONZA GROUP AG-23.32%46 073
IQVIA HOLDINGS INC.-12.88%45 135
SEAGEN INC.10.05%32 099
ALNYLAM PHARMACEUTICALS, INC.37.90%27 533